Vertex Pharmaceuticals (VRTX)

Sales/Maturities of Investments

$2.42B

Quarterly · Period ending: · USD

VRTX logo

VRTX Sales/Maturities of Investments

Latest reported$2.42B
VRTX Quarterly Sales/Maturities of Investments ($0.00 → $2.42B)
High-resolution chart · PNG

VRTX sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
2,424,600,000
2,209,100,000
1,107,800,000
1,329,300,000
1,838,700,000
1,637,600,000
1,460,200,000
1,112,300,000
1,182,600,000
710,500,000
218,100,000
331,200,000
334,900,000
50,000,000
484,100,000
193,600,000
112,600,000
129,700,000
47,167,000
230,862,000
103,199,000
118,072,000
475,895,000
60,745,000
141,088,000
132,181,000
195,715,000
146,438,000
121,589,000
107,118,000
123,170,000
137,378,000
76,663,000
94,365,000
122,065,000
78,267,000
70,489,000
98,393,000
222,183,000
203,063,000
201,143,000
131,173,000
262,855,000
62,863,000
370,302,000
371,423,000
354,538,000
402,194,000
424,662,000
376,544,000
505,934,000
1,011,455,000
400,371,000
430,535,000
426,613,000
439,126,000
318,201,000
183,987,000
92,917,000
135,094,000
251,667,000
536,362,000
305,015,000
461,650,000
333,867,000
184,274,000
271,023,000
171,783,000
171,451,000
174,006,000
182,871,000
160,405,000
55,194,000
29,178,000
149,373,000
188,917,000
176,316,000
241,014,000
35,914,000
103,232,000
76,308,000
86,984,000
55,446,000
54,067,000
69,933,000
63,964,000
59,539,000
50,859,000
105,463,000
76,490,000
163,345,000
0
0
191,163,000
127,200,000
128,780,000
201,388,000
270,669,000
272,006,000
471,751,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.